Tag : cardiac biomarkers

Enhances mission to advance the care of patients facing the potential diagnosis of a neurodegenerative disease CND Life Sciences (CND), a medical technology company pioneering the...

Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions Proscia®, a global leader in AI-enabled pathology solutions for...

Vikas Ahuja brings over 20 years of strategic business experience in the life sciences industry from Quest Diagnostics, Ambry Genetics and Mallinckrodt Pharmaceuticals Nucleai, a...

Fountain Life CORE provides a recurring, comprehensive, longevity-focused blood panel paired with expert analysis and ongoing guidance from a Fountain Life longevity physician and health...

Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay...

Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging...

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic...

Ambry Genetics (Ambry), a leader in clinical diagnostic testing, and Tempus, a leader in artificial intelligence and precision medicine, announced today that they have entered into a...

The partnership will enable insurers to leverage health and wellness monitoring technology for streamlined underwriting and enhanced user experience Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS),...